Beranda › Kanker (semua jenis) › Vermont
Uji klinis Kanker (semua jenis) di Vermont
7 studi untuk Kanker (semua jenis) mencari peserta di lokasi di Vermont.
Kota di Vermont
Teks studi resmi (Bahasa Inggris)
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- White River Junction Veterans Healthcare System, White River Junction
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT05796375A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The University of Vermont Medical Center Inc., Burlington
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581Project: Every Child for Younger Patients With Cancer
- University of Vermont and State Agricultural College, Burlington
Menerima pesertaStudi observasional
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
- University of Vermont Cancer Center, Burlington
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07061652Care Coordination Educational Intervention Study for Patients From Rural Areas With Early Stage Cancer
- University of Vermont Cancer Center, Burlington
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mei 2026 · NCT05723250DOAC - Dosing Options in AntiCoagulation Prophylaxis
- University of Vermont Medical Center, Burlington
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Feb 2026 · NCT07005024Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of Vermont Medical Center, Burlington
- University of Vermount and Sate Agricultural College, Burlington
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Nov 2024 · NCT03860883Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.